Stockreport

Terran Biosciences prepares for trials of schizophrenia drug [Yahoo! Finance]

Bristol-Myers Squibb Company  (BMY) 
Last bristol-myers squibb company earnings: 2/6 07:05 am Check Earnings Report
US:NYSE Investor Relations: bms.com/investors.html
PDF Terran Biosciences CEO Sam Clark told the Clinical Trials Arena that TerXT is a long-acting pro-drug of Bristol Myers Squibb's (BMS) KarXT, a combination of xanomeline [Read more]